Radiopharmacy and translational cancer theranostic
Description
Description: My lab is seeking for a highly motivated PhD student to develop novel anti-cancer theranostics.
Overview: The research will focus on the development and evaluation of novel theranostics against cancer-specific antigens. This PhD project will combine both basic and applied aspects of radiopharmaceutical research and provides an opportunity to work in an interdisciplinary environment with access to state-of-the-art facilities on all aspects of biologic theranostics R&D (live-cell imaging, in vivo molecular imaging, scRNAseq/multi-omics etc.), and a GMP cyclotron facility for potential translational research, all located at the new Centre intégré de Cancérologie (CIC), at the Centre de recherche CHU de Québec- Université Laval (CHUL).
Key responsibilities:
- Conduct independent research under the supervision of Dr. Fonge and collaborator
- Develop and investigate new diagnostic and therapeutic agents
- Perform laboratory experiments, data collection and analysis
- Collaborate with other laboratory members
- Present research findings at national and international conferences
- Write manuscripts and publish in peer-reviewed journals
What we offer:
- Access to new and innovative technologies and multidisciplinary expertise
- Opportunity for professional development such as attending conferences, journal clubs, seminars, etc.
- Competitive stipend and benefits package
- A dynamic and collaborative research environment
- Travel grants competitions
Research Field
- Nuclear medicine
- Theranostics
- Precision medicine
- Tumor immune microenvironment
- Radioisotopes
- Non-small cell lung cancer
- Small cell lung cancer
- Triple negative breast cancer
Research Supervisor
Humphrey Fonge
Research Environment
Oncology Axis - CRCHU de Quebec - University Laval
The work environment consists of the cyclotron, laboratories and offices located at the Centre intégré de cancérologie (CIC). The CIC is a new complex of the CHU de Québec - Université Laval located on the site of the Hôpital de l'Enfant-Jésus and is the largest cancer centre in Québec. Prof. Humphrey Fonge of Université Laval's Faculty of Pharmacy oversees the lab's activities and coordinates the work of several predoctoral students, postdoctoral fellows and other research professionals.
Given the use of nuclear substances or radioactive isotopes, the laboratory is among the first users of pharmaceutical products manufactured within the cyclotron of the CHU de Québec - Université Laval. Prof. Fonge's laboratory brings extensive experience in nuclear medicine and will complement the existing team at the new cyclotron facility with the aim of advancing new agents in the care of cancer patients. The laboratory's research work has led to the publication of numerous high-impact factor articles
Web Site
Financial Aid Available by Program of Study
Doctorate in Pharmacy Science
Program descriptionFinancial Aid Available*
Financial Aid Related to Research Project
Information unavailable
Program-Specific Financial Aid
Graduate Studies Awards
| Milestone |
Amount |
| Submission of the project outline |
$2,000 |
| Successful completion of the doctoral exam |
$1,000 |
| Successful completion of all courses by the end of the 8th semester |
$500 |
| Principal author of a first scientific article by the end of the 12th semester |
$1,000 |
| Principal author of a second scientific article by the end of the 12th semester |
$1,500 |
| Principal author of a literature review article or a third article by the end of the 12th semester |
$750 |
| Successful completion of the doctoral seminar and first submission of the dissertation by the end of the 12th semester |
$1,500 |
| Dissertation defence and final submission within 4 weeks of the defence |
$2,500 |
| Total |
$10,750 |
Teaching and Research Fund: Maximum amounts up to $17,500–$25,500 for doctoral students.
Université Laval: Student Financial Aid
Supplemental Tuition Fee Exemption Scholarship Program: Entitles international students to pay Canadian student tuition fees, for overall savings of around $40,000.
* Amounts shown represent maximum financial aid available. Certain conditions apply. Subject to change without prior notice. For further information, contact sponsoring organizations directly.
Desired Profile
- Medecine
- Pharmacy
- Nursing
- Biomedical Science
- Biochemistry
- Biology
- Chemistry
Requirements and Conditions
- A master's degree with minimum second upper class or ideally first-class degree in pharmacy, pharmacology, molecular biology, pharmaceutical chemistry or related fields.
- Strong background in either pharmacology, pharmaceutical sciences, nuclear medicine, immunology, oncology drug discovery and development particularly relevant to monoclonal antibodies and peptides.
- Excellent problem-solving and critical thinking abilities.
- Ability to work both independently and as part of a team.
- Good laboratory skills and experience.
- Strong written and verbal communication skills in English and/or French.
Required Documentation
- Lettre de recommandation
- Cover letter
- Curriculum vitæ
- Student transcript
Please send your research interest, motivation for applying, your most recent CV and transcripts to humphrey.fonge@crchudequebec.ulaval.ca by April 30, 2025
Application Deadline
April 30, 2025
Find Out More
Humphrey Fonge
Professeur
Faculté de pharmacie
humphrey.fonge@crchudequebec.ulaval.ca